Usage of weight loss medications including Glucagon-like peptide-1 receptor agonists such as Ozempic has skyrocketed in the U.S. in the last year, affecting numerous medical specialties.
Usage of weight loss medications including Glucagon-like peptide-1 receptor agonists such as Ozempic has skyrocketed in the U.S. in the last year, affecting numerous medical specialties.